Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05183763 · ClinicalTrials.gov registry record · NA
Medication Adherence Program
A NA study of Hypertension and Medication Adherence, sponsored by Tulane University.
- Recruiting
- Registry status
- NA
- Development phase
- 402
- Enrollment target
- 5
- Study locations
NCT05183763: Recruiting NA study of Hypertension and Medication Adherence, sponsored by Tulane University.
NCT05183763 is a NA study of Hypertension and Medication Adherence that is actively recruiting participants, run by Tulane University. The registered enrollment target is 402 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (89% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05183763, a NA study of Hypertension and Medication Adherence, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- NA
- Development phase
- 402 participants
- Enrollment target
- 5
- Study locations
Study Summary
Randomized controlled trial testing the efficacy of the Supporting Tailored Adaptive change and Reinforcement for Medication Adherence Program (STAR-MAP), a health coaching approach that aims to improve antihypertensive medication adherence, blood pressure control, and quality of life. Participants (n=402) \>=40 years old with a diagnosis of hypertension, uncontrolled blood pressure, and low antihypertensive medication adherence will be recruited through a statewide health insurer, Blue Cross Blue Shield of Louisiana, and randomized to receive either interactive health coaching sessions with medication reminder tools (intervention) or medication reminder tools only (control) over one year. Data will be collected from participants at baseline, 6 months, 12 months, and 24 months using questionnaires, physical measurement (height, weight, blood pressure), a computer-based single-category implicit association test, and laboratory analysis of antihypertensive medication urinary metabolites.
Primary Outcome
Proportion of days covered (PDC) calculated from pharmacy refill data
Conditions Studied
Interventions
- BEHAVIORAL STAR-MAP health coaching
- BEHAVIORAL Medication reminder tools
Study Locations (5)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
- Tulane Doctors Dermatology & Multispecialty Clinic - Covington
- Tulane Doctors Heart & Vascular and Primary Care Clinic - Metairie
- Tulane University Clinical and Translational Unit - New Orleans
- LSU Health Sciences Shreveport Clinical Trials Office - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2022-03-07 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT05183763 shows while recruiting
NCT05183763 is an interventional study that assigns participants to a tested intervention. The registered 402 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which STAR-MAP health coaching is the first listed.
NCT05183763 lists 5 locations in 1 state (Louisiana).
Frequently Asked Questions
What is clinical trial NCT05183763 about?
NCT05183763 is a clinical study titled "Medication Adherence Program". Randomized controlled trial testing the efficacy of the Supporting Tailored Adaptive change and Reinforcement for Medication Adherence Program (STAR-MAP), a health coaching approach that aims to improve antihypertensive medication adherence, blood pressure control, and quality of life. Participants ...
What is the current status of trial NCT05183763?
This trial is currently recruiting. It is a NA study. The enrollment target is 402 participants. The study started on 2022-03-07. Estimated completion is 2027-04-30.
What conditions does trial NCT05183763 study?
This clinical trial studies the following conditions: Hypertension, Medication Adherence, Behavior and Behavior Mechanisms.
What interventions are being tested in trial NCT05183763?
The interventions under investigation include: STAR-MAP health coaching (BEHAVIORAL), Medication reminder tools (BEHAVIORAL).
Who is sponsoring clinical trial NCT05183763?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05183763 being conducted?
This trial has 5 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05183763's enrollment target sits among peer trials
402 145th of 470 higher than 326 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
- NCT05647122 · 403 participants · Phase 1
First in Human Study of AZD9592 in Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI